VIROLOGICAL CHARACTERIZATION OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN A HEALTH-CARE WORKER FOLLOWING NEEDLESTICK INJURY

被引:40
作者
PRATT, RD
SHAPIRO, JF
MCKINNEY, N
KWOK, S
SPECTOR, SA
机构
[1] UNIV CALIF SAN DIEGO,CTR GENET MOLEC,LA JOLLA,CA 92093
[2] ROCHE MOLEC SYST,BRANCHBURG,NJ
[3] UNIV CALIF SAN DIEGO,DEPT PEDIAT,LA JOLLA,CA 92093
关键词
D O I
10.1093/infdis/172.3.851
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A health care worker (HCW) was infected via needlestick with human immunodeficiency virus (HIV) type 1 from a subject with AIDS who harbored a zidovudine-resistant, syncytium-inducing (SI) HIV strain. The phenotypic characteristics of the HIV-1 isolates obtained from the HCW and markers of virus load were followed for 20 months. Although the HCW was initially infected with an SI strain, within 75 days of infection the isolate became non-SI and remained so for greater than or equal to 635 days. Even though the AIDS patient had a zidovudine-resistant virus, the HCW was infected with a zidovudine-sensitive virus. Plasma RNA levels peaked 20 days after infection, declined rapidly within 2 weeks, and remained stable for the duration of follow-up. Similarly, the HCW's CD4 lymphocyte count remained stable throughout the study, Thus, selection for non-SI and zidovudine-sensitive virus occurred in the HCW, who, after initial symptomatic infection associated with high levels of plasma HIV-1 RNA, developed low plasma RNA copy numbers and stable CD4 lymphocyte counts.
引用
收藏
页码:851 / 854
页数:4
相关论文
共 15 条
[1]   ORDERED APPEARANCE OF ZIDOVUDINE RESISTANCE MUTATIONS DURING TREATMENT OF 18 HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS [J].
BOUCHER, CAB ;
OSULLIVAN, E ;
MULDER, JW ;
RAMAUTARSING, C ;
KELLAM, P ;
DARBY, G ;
LANGE, JMA ;
GOUDSMIT, J ;
LARDER, BA .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) :105-110
[2]   HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION [J].
CLARK, SJ ;
SAAG, MS ;
DECKER, WD ;
CAMPBELLHILL, S ;
ROBERSON, JL ;
VELDKAMP, PJ ;
KAPPES, JC ;
HAHN, BH ;
SHAW, GM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :954-960
[3]  
COOPER DA, 1985, LANCET, V1, P537
[4]   TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
DAAR, ES ;
MOUDGIL, T ;
MEYER, RD ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :961-964
[5]   MICROCULTURE ASSAY FOR ISOLATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND FOR TITRATION OF INFECTED PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
DIMITROV, DH ;
MELNICK, JL ;
HOLLINGER, FB .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (04) :734-737
[6]   PROPHYLACTIC ZIDOVUDINE AFTER OCCUPATIONAL EXPOSURE TO THE HUMAN IMMUNODEFICIENCY VIRUS - AN INTERIM ANALYSIS [J].
HENDERSON, DK ;
GERBERDING, JL .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (02) :321-327
[7]  
JAPOUR AJ, 1993, ANTIMICROB AGENTS CH, V336, P585
[8]   FAILURE OF ZIDOVUDINE PROPHYLAXIS AFTER ACCIDENTAL EXPOSURE TO HIV-1 [J].
LANGE, JMA ;
BOUCHER, CAB ;
HOLLAK, CEM ;
WILTINK, EHH ;
REISS, P ;
VANROYEN, EA ;
ROOS, M ;
DANNER, SA ;
GOUDSMIT, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (19) :1375-1377
[9]   ZIDOVUDINE RESISTANCE PREDICTED BY DIRECT DETECTION OF MUTATIONS IN DNA FROM HIV-INFECTED LYMPHOCYTES [J].
LARDER, BA ;
KELLAM, P ;
KEMP, SD .
AIDS, 1991, 5 (02) :137-144
[10]   RAPID AND SIMPLE PCR ASSAY FOR QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA IN PLASMA - APPLICATION TO ACUTE RETROVIRAL INFECTION [J].
MULDER, J ;
MCKINNEY, N ;
CHRISTOPHERSON, C ;
SNINSKY, J ;
GREENFIELD, L ;
KWOK, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (02) :292-300